MetLife Investment Management’s Verrica Pharmaceuticals VRCA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,189	Closed	-$86.7K	–	2913
2024 Q2	$86.7K	Buy	+1,189	New	+$86.7K	﹤0.01%	2664
2023 Q3	–	Sell	-1,119	Closed	-$64.6K	–	2986
2023 Q2	$64.6K	Buy	+1,119	New	+$64.6K	﹤0.01%	2870